Prostate-specific antigen doubling time following radium-223 treatment as a predictor of the clinical course in patients with metastatic castration-resistant prostate cancer

OBJECTIVES: To identify useful biomarkers by reviewing laboratory data for a predictor of the clinical course following treatment with radium-223 dichloride (Ra-223) in patients with metastatic castration-resistant prostate cancer. METHODS: Eighteen metastatic castration-resistant prostate cancer pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Gen, Akazawa, Kohei, Ikeda, Taro, Ikeda, Yohei, Hara, Noboru, Nishiyama, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126629/
https://www.ncbi.nlm.nih.gov/pubmed/37113623
http://dx.doi.org/10.1177/20503121231168493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126629/
https://www.ncbi.nlm.nih.gov/pubmed/37113623
http://dx.doi.org/10.1177/20503121231168493

Ejemplares similares